Stock Market
JPMorgan CEO Warns of Possible Further Interest Rate Hikes Due to Persistent Inflation
JPMorgan Chase CEO Jamie Dimon has expressed concerns about the possibility of the Federal Reserve implementing further interest rate hikes due to “stickier” inflation, cautioning...
Stock Futures Rally as Fed Signals End to Rate-Hike Campaign
Stock futures surged on Thursday, with investors expressing growing confidence that the Federal Reserve was nearing the conclusion of its rate-hike campaign. The Dow Jones...
Stocks Surge as Federal Reserve Maintains Highest Interest Rates in 22 Years
In a significant move for the financial markets, the Federal Reserve opted to keep interest rates at their highest range in over two decades at...
Benchmark 10-year Treasury Yields Hit Two-Week Lows as Fed Holds Steady on Rates
Benchmark 10-year Treasury yields dipped to their lowest levels in two weeks on Wednesday following the Federal Reserve’s decision to maintain interest rates, with a...
Tenon Medical Announces 1:10 Reverse Stock Split, Faces Stock Decline
In a move aimed at reshaping its financial structure, Tenon Medical, a company at the forefront of revolutionizing care for patients afflicted with specific sacroiliac...
BioSig Technologies’ Stock Skyrockets Following Patent Milestone
BioSig Technologies, a leading medical technology company specializing in intracardiac signal visualization, announced a significant milestone today with the reception of multiple new utility patents...
Blue Ridge Bankshares Stock Sees Sharp Decline Following Q3 Financial Report
Blue Ridge Bankshares, the parent company of Blue Ridge Bank, National Association, and BRB Financial Group, has released its financial results for the quarter ending...
TG Therapeutics Reports Strong Q3 Results, Bolstered by BRIUMVI Success, Stock Soars
TG Therapeutics, a biopharmaceutical company, unveiled its financial results for the third quarter (Q3) ending September 30, 2023, coupled with recent company milestones, sparking a...
FTC Urged to Examine Exxon Mobil, Chevron Mergers Amidst Antitrust Concerns
US Senate Majority Leader Charles Schumer has voiced apprehensions regarding the recent acquisitions of Exxon Mobil and Chevron Corp., marking them as two of the...
ZyVersa Therapeutics Stock Surges on Breakthrough MS Research
ZyVersa Therapeutics, a clinical stage specialty biopharmaceutical company specializing in the development of first-in-class drugs for the treatment of inflammatory and renal diseases, has announced...
